PASCALE, Rosa Maria
 Distribuzione geografica
Continente #
NA - Nord America 6.321
AS - Asia 3.773
EU - Europa 2.395
SA - Sud America 2.236
AF - Africa 128
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 13
Totale 14.882
Nazione #
US - Stati Uniti d'America 6.164
BR - Brasile 2.021
SG - Singapore 1.625
CN - Cina 1.224
UA - Ucraina 826
DE - Germania 362
SE - Svezia 297
HK - Hong Kong 273
IT - Italia 239
FI - Finlandia 153
TR - Turchia 131
GB - Regno Unito 125
FR - Francia 124
VN - Vietnam 112
CA - Canada 68
AR - Argentina 64
IQ - Iraq 64
CZ - Repubblica Ceca 52
IN - India 49
MX - Messico 49
RU - Federazione Russa 48
ZA - Sudafrica 44
BE - Belgio 40
UZ - Uzbekistan 37
BD - Bangladesh 36
VE - Venezuela 35
EC - Ecuador 33
PK - Pakistan 30
ID - Indonesia 27
MA - Marocco 26
AT - Austria 25
JP - Giappone 25
CO - Colombia 20
IR - Iran 20
KR - Corea 20
PL - Polonia 19
PY - Paraguay 19
AE - Emirati Arabi Uniti 18
ES - Italia 17
LT - Lituania 15
AU - Australia 14
JO - Giordania 14
CL - Cile 13
TN - Tunisia 13
AZ - Azerbaigian 12
UY - Uruguay 12
EU - Europa 11
PE - Perù 11
NP - Nepal 10
PA - Panama 9
SN - Senegal 9
HN - Honduras 8
KE - Kenya 8
NL - Olanda 8
BG - Bulgaria 7
DZ - Algeria 7
JM - Giamaica 7
RO - Romania 7
BO - Bolivia 6
DO - Repubblica Dominicana 5
IL - Israele 5
KZ - Kazakistan 5
OM - Oman 5
SA - Arabia Saudita 5
AO - Angola 4
EG - Egitto 4
PS - Palestinian Territory 4
RS - Serbia 4
AL - Albania 3
AM - Armenia 3
CH - Svizzera 3
CI - Costa d'Avorio 3
EE - Estonia 3
KG - Kirghizistan 3
NI - Nicaragua 3
PT - Portogallo 3
SV - El Salvador 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BW - Botswana 2
CG - Congo 2
DK - Danimarca 2
ET - Etiopia 2
IE - Irlanda 2
LB - Libano 2
ML - Mali 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
QA - Qatar 2
BF - Burkina Faso 1
BS - Bahamas 1
BY - Bielorussia 1
CR - Costa Rica 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
Totale 14.867
Città #
Dallas 2.026
Chandler 955
Singapore 911
Jacksonville 488
Princeton 272
Hong Kong 271
Beijing 255
Dearborn 200
Nanjing 198
Ann Arbor 165
Ashburn 164
São Paulo 147
Wilmington 137
Sassari 128
Nanchang 101
Shanghai 93
Boardman 90
Rio de Janeiro 81
Los Angeles 77
Izmir 76
Tianjin 56
Changsha 53
Woodbridge 53
Shenyang 51
Santa Clara 50
Ho Chi Minh City 49
Belo Horizonte 45
Brno 45
Munich 41
Brussels 40
New York 40
The Dalles 40
Hebei 38
Jinan 38
Columbus 35
Council Bluffs 35
Tashkent 35
Baghdad 34
Brasília 32
Jiaxing 32
Toronto 31
Norwalk 30
Falls Church 29
Helsinki 27
Zhengzhou 27
Campinas 26
Porto Alegre 26
Hangzhou 25
Ningbo 24
Tokyo 24
Guangzhou 23
Hanoi 22
London 22
Mountain View 22
Buffalo 21
Curitiba 21
San Francisco 20
Andover 19
Brooklyn 19
Johannesburg 19
Nuremberg 19
Ribeirão Preto 19
Seoul 19
Augusta 18
Boston 18
Goiânia 18
Kunming 18
Warsaw 18
Guarulhos 17
Salvador 17
San Mateo 17
Leawood 16
Praia Grande 15
Amman 14
Ardabil 14
Atlanta 14
Fortaleza 14
Montreal 14
Santo André 14
Stockholm 14
Ankara 13
Denver 13
Guayaquil 13
Mexico City 13
Taizhou 13
Aracaju 12
Baku 12
Maceió 12
Monmouth Junction 12
Orem 12
Osasco 12
Pelotas 12
Recife 12
Sorocaba 12
Betim 11
Campo Grande 11
Chennai 11
Cotia 11
Erbil 11
Frankfurt am Main 11
Totale 8.720
Nome #
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis 324
Alterations of methionine metabolism in hepatocarcinogenesis: the emergent role of glycine N-methyltransferase in liver injury 205
An expression signature of phenotipic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis 200
1-5-formyltetrahydrofolate and 1-5-methyltetrahydrofolate rescue in L-1210 leukemia treated with high methotrexate doses 195
5' Methylthioadenosine administration prevents lipid peroxidation and fibrogenesis induced in rat liver by carbon tetrachloride intoxication 186
Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis 168
Chemoprevention of rat liver carcinogenesis by S-adenosyl-L-methionine: a long-term study. 165
. Chemoprevention by S-adenosyl-L-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promoted by orotic acid. 162
Analysis of loss of heterozygosity in neoplastic nodules induced by diethylnitrosomine in the resistant BFF1 rat strain 160
Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans 160
Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain 159
Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-kappa B and Mat1A genes in the early stages of rat liver carcinogenesis 158
Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease 157
Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans 157
c-myc amplification in pre-malignant and malignant lesions induced in rat liver by the resistant hepatocyte model 157
An infernal cross-talk between oncogenic β-catenin and c-Met in hepatocellular carcinoma: Evidence from mouse modeling 152
INHIBITION OF 3-HYDROXY-3-METHYLGLUTARY-COA REDUCTASE ACTIVITY AND GENE EXPRESSION BY DEHYDROEPIANDROSTERONE IN PRENEOPLASTIC LIVER NODULES 151
Benzo(a)pyrene metabolism by lymphocytes from normal individuals and individuals carrying the Mediterranean variant of glucose-6-phosphate dehydrogenase. 150
Amplification of c-myc oncogene in preneoplastic e neoplastic lesions induced in rat liver by the resistant hepatocyte protocol 147
Chemoprevention of hepatocarcinogenesis: S.adenosyl-L-methionine 144
Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53 141
Experimental models to define the genetic predisposition to liver cancer 140
Chemopreventive N-(4-hidroxyphenyl)retinamide targets NF-kB and Mat1A genes in early stages of rat liver carcinogenesis. 139
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 139
Role of HSP90,CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer 136
Dependence of benzo(a)pyrene metabolism on NADPH pool in normal and glucose-6-phosphate dehydrogenase deficient human fibroblasts. 135
Comparative effects of L-methionine, S-adenosyl-L-methionine and 5'-methylthioadenosine on the growth of preneoplastic lesions and DNA methylation in rat liver during the early stages of hepatocarcinogenesis 132
SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis 131
Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells 131
Dual-Specific Phosphatase 1 Ubiquitination in Extracellular Signal-Regulated Kinase-Mediated control of Grawth in Human Hepatocellular Carcinoma 130
MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting MAT2A and MAT2B genes 130
Deregulation of methionine metabolism as determinant of progression and prognosis of hepatocellular carcinoma 128
Alterations of ornithine decarboxylase gene during the progression of rat liver carcinogenesis. 127
New insights on the role of epigenetic alterations in hepatocellular carcinoma 126
Correlation between S-adenosyl-L-methionine content and production of c-myc, c-Ha-ras, and c-Ki-ras mRNA transcripts in the early stages of rat liver carcinogenesis. 125
Effect of S-adenosyl-L-methionine on the development of preneoplastic foci and the activity of some carbohydrate metabolizing enzymes in the liver, during experimental hepatocarcinogenesis. 125
Role of transcriptional and postttranscriptional regulation of methionine adenosyltransferases in liver cancer progression. 123
Inhibition by dehydroepiandrosterone of growth and progression of persistent liver nodules in experimental rat liver carcinogenesis 122
Combined CDK4/6 and pan-mTOR inhibition is synergistic against intrahepatic cholangiocarcinoma 122
Implication of Bcl 2 family genes in basal and D amphetamine induced apoptosis in preneoplastic and neoplastic rat liver lesions 121
S-Adenosylmethionine Regulates Apurinic/Apyrimidinic Endonuclease 1 Stability: Implication in Hepatocarcinogenesis 119
ROLE OF YAP SIGNALLING DEREGULATION IN THE GENETIC SUSCEPTIBILITY TO HEPATOCARCINOGENESIS, AND STEMNESS AND AGGRESSIVITY OF LIVER CANCER 119
Oncogene-dependent addiction to carbohydrate-responsive element binding protein in hepatocellular carcinoma 118
S-adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancers 118
The degradation of cell cycle regulators by SKP2/CKS1 ubiquitin ligase is genetically controlled in rodent liver cancer and contributes to determine the susceptibility to the disease. 116
Identification and chromosome mapping of loci predisposing to colorectal cancer that control Wnt/b-catenin pathway and progression of early lesions in the rat 115
THE BN RAT STRAIN CARRIES DOMINANT HEPATOCARCINOGEN RESISTANCE LOCI 115
Inhibition of promotion and persistent nodule growth by S-adenosyl-L-methionine in rat liver carcinogenesis: role of remodeling and apoptosis 114
Chromosome mapping of multiple loci affecting the genetic predisposition to rat liver carcinogenesis 114
Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines in vitro and AKT-driven hepatocarcinogenesis in mice 114
Stearoyl-CoA desaturase 1 (Scd1) gene overexpression is associated with genetic predisposition to hepatocarcinogenesis in mice and rats 114
Differential effects of dehydroepiandrosterone and deoxyribonucleosides on DNA synthesis and de novo cholesterogenesis in hepatocarcinogenesis in rats. 113
Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value 112
Blood cell count indexes of systemic inflammation in carotid artery disease: current evidence and future perspectives 112
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice 112
Alterations of methionine metabolism as potential targets for the prevention and therapy of hepatocellular carcinoma 112
Protooncogene methylation and expression in regenerating liver and preneoplastic liver nodules induced in the rat by diethylnitrosamine: effect of variations of S-adenosylmethionine:S-adenosylhomocysteine ratio. 111
Laboratory test alterations in patients with COVID-19 and non COVID-19 interstitial pneumonia: a preliminary report 110
Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans 110
Identification of genetic loci controlling hepatocarcinogenesis on rat chromosomes 7 and 10 108
Control of glucose-6-phosphate dehydrogenase deficiency on the formation of mutagenic and carcinogenic metabolites derived from benzo(a)pyrene. 108
Modulatory effect of glucose-6-phosphate dehydrogenase deficiency on benzo(a)pyrene toxicity and transforming activity for in vitro-cultured human skin fibroblasts. 106
SNAI1 promotes the cholangiocellular phenotype, but not epithelial-mesenchymal transition, in a murine hepatocellular carcinoma model 106
Inhibition by dehydroepiandrosterone of liver preneoplastic foci formation in rats after initiation-selection in experimental carcinogenesis. 106
Long-term dehydroepiandrosterone and 16alfa-fluoro-5-androsten-17-one administration enhances DNA synthesis and induces expression of c-fos and c-Ha-ras in a selected population of preneoplastic lesions in liver of diethylnitrosamine-initiated rats 106
Regulation of Amphiregulin Gene Expression by β-Catenin Signaling in Human Hepatocellular Carcinoma Cells: A Novel Crosstalk between FGF19 and the EGFR System 105
Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype 105
Genetic Control of Resistance to Hepatocarcinogenesis by the Mouse Hpcr3 Locus 104
Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC 104
Phenotypic reversion of rat neoplastic liver nodules is under genetic control 103
Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease 103
Persistent chemopreventive effect of S-adenosyl-L-methionine on the development of liver putative preneoplastic lesions induced by thiobenzamide in diethylnitrosamine-initiated rats 103
Polygenic control of hepatocarcinogenesis in Copenhagen x F344 rats 102
S-adenosylmethionine regulates dual-specificity mitogen-activated protein kinase phosphatase expression in mouse and human hepatocytes. 102
DNA-PKcs: A promising therapeutic target in human hepatocellular carcinoma? 102
The post-transcriptional dysregulation of methionine adenosyl-transferases is crucial for the progression of rat and human liver cancer. 47° Annual Meeting of the European Association for Study of the Liver (EASL) Aprile 18-22, 2012 99
GENETIC AND EPIGENETIC CONTROL OF MOLECULAR ALTERATIONS IN HEPATOCELLULAR CARCINOMA 98
Decreased stimulation by 12-O-tetradecanoylphorbol-13-acetate of superoxide radical production by polymorphonuclear leukocytes carrying the Mediterranean variant of glucose-6-phosphate dehydrogenase. 97
Reversal by ribo- and deoxyribonucleosides of dehydroepiandrosterone-induced inhibition of enzyme altered foci in the liver of rats subjected to the initiation--selection process of experimental carcinogenesis. 97
The mTORC2-Akt1 Cascade Is Crucial for c-Myc to Promote Hepatocarcinogenesis in Mice and Humans 96
Effect of the variations of S-adenosyl-L-methionine liver content on fat accumulation and ethanol metabolism in ethanol-intoxicated rats 94
Ruolo di HSP90, CDC37 e CRM1 come modulatori dell’attività di p16 INK4A nella cancerogenesi epatica di ratto e nel carcinoma epatocellulare umano 92
The warburg effect 97 years after its discovery 92
New putative prognostic markers and therapeutic targets for the molecular approach to treatment of hepatocellular carcinoma 92
Sulfatase 1: A new Jekyll and Hyde in hepatocellular carcinoma? 92
the role of S-adenosylmethionine in the regulation of glutathione pool and acetaldehyde production in acute ethanolintoxication 91
Epigenetics of liver cancer progression: Role of transcriptional and post-transcriptional regulation of methionine adenosyltransferases in liver cancer progression. 91
Multifocal hepatocellular carcinoma: intrahepatic metastasis or multicentric carcinogenesis? 91
Variations of ornithine decarboxylase activity and S-adenosyl-L-methionine and 5'-methylthioadenosine contents during the development of diethylnitrosamine-induced liver hyperplastic nodules and hepatocellular carcinoma. 90
Connective tissue growth factor autocriny in human hepatocellular carcinoma: oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activation. 88
Modulation of P16INK4 activity by HSP90, Cdc37 and CRM1 influences the progression of preneoplastico lesions in rats with different predisposition to liver cancer and the prognosis of human hepatocellular carcinoma 87
Prognostic markers and putative therapeutic targets for hepatocellular carcinoma. 85
Role of phosphatidylethanolamine methylation in the synthesis of phosphatidylcholine by hepatocytes isolated from choline-deficient rats. 84
INTERACTION OF MAJOR GENES PREDISPOSING TO HEPATOCELLULAR CARCINOMA WITH GENES ENCODING SIGNAL TRANSDUCTION PATHWAYS INFLUENCES TUMOR PHENOTYPE AND PROGNOSIS 84
Inhibition of 3-hydroxy-3- methylglutaryl-CoA reductase activity and gene expression by dehydroepiandrosterone in preneolastic liver nodules 83
Role of Dehydroepiandrosterone in Experimental and Human Carcinogenesis 83
Ras-driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic control 82
Instabilità genomica nel carcinoma mammario 82
Focal loss of long non-coding RNA-PRAL, as determinant of cell function and phenotype of hepatocellular carcinoma 82
Construction of a phylogenetic tree for inbred strains of rat by arbitrarily primed polymerase chain reaction (AP-PCR). 81
Totale 12.134
Categoria #
all - tutte 62.162
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.162


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021774 0 0 0 0 0 72 143 8 188 180 148 35
2021/2022784 116 8 6 11 24 33 45 46 73 42 84 296
2022/20231.658 179 147 43 293 152 279 0 189 278 6 57 35
2023/2024390 89 27 13 16 54 15 0 14 0 3 53 106
2024/20254.323 30 39 223 120 204 149 323 745 1.433 686 258 113
2025/20264.218 314 1.541 951 767 554 91 0 0 0 0 0 0
Totale 15.022